InflaRx

-$0.09 (-6.25%) As of 1:43 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell InflaRx and other ETFs, options, and stocks.

About IFRX

InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is vilobelimab.

CEO
Niels Christoph Riedemann
Employees
59
Headquarters
Jena, Thueringen
Founded
2007

IFRX Key Statistics

Market cap
59.68M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.11M
High today
$1.46
Low today
$1.35
Open price
$1.46
Volume
9.32K
52 Week high
$5.69
52 Week low
$0.7762

IFRX Earnings

-$0.40
-$0.27
-$0.13
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure